Skip to main content Skip to section navigation Skip to footer
TCBiopharm.com

TC BioPharm Limited

  • Investors
  • Overview
  • News
    • Overview
    • Press Releases
    • Media Coverage
    • Email Alerts
  • Events & Presentations
    • Overview
    • Events
    • Presentations
  • Company Info
    • Overview
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • General Meeting
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents

Press Releases

News

News

  • Overview
  • Press Releases
  • Media Coverage
  • Email Alerts
Apr 24, 2019 4:39am EDT

TC BioPharm Initiates Phase I Trial of Allogeneic Gamma Delta T Cell Therapy in Acute Myeloid Leukemia Patients

Mar 29, 2019 5:30am EDT

Allogeneic CAR-T Specialists TC BioPharm Appoint Prof John Anderson as Scientific and Medical Director

Feb 25, 2019 4:00am EST

Immunotherapy Company TC BioPharm Partners with Trinity College Dublin to Develop V Delta 1 γδ T Cell-based Cancer Treatments

Jan 22, 2019 5:55am EST

TC BioPharm creates allogeneic cell banks for CAR-T cancer therapy products

  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
  • Visit us on Facebook
  • Visit us on Twitter
  • Visit us on LinkedIn
©2023 TC BioPharm Limited. All Rights Reserved.
Privacy Policy Disclaimer Sitemap

This website stores cookies on your computer. These cookies, which also could include third party cookies, are used (among other purposes) to improve the website and provide more personalized services to you. To find out more about how we use cookies and how to change your settings, see our Privacy Policy.

I Accept